McConnell I, Klein G, Macanovic M, Gorman N T, Raniwalla J
Eur J Immunol. 1981 Feb;11(2):132-5. doi: 10.1002/eji.1830110213.
Cells isolated directly from primary biopsies of Burkitt's lymphoma were found to activate the alternative complement pathway in hypogammaglobulinemic human serum. In contrast, cells isolated from patients with either acute lymphoblastic leukemia, chronic lymphocytic leukemia or chronic myeloid leukemia did not activate. No defects in the ability of Burkitt's lymphoma sera to support alternative pathway activation were detected.
从伯基特淋巴瘤原发性活检中直接分离出的细胞，被发现可在低丙种球蛋白血症患者血清中激活替代补体途径。相比之下，从急性淋巴细胞白血病、慢性淋巴细胞白血病或慢性粒细胞白血病患者中分离出的细胞则不会激活。未检测到伯基特淋巴瘤血清支持替代途径激活的能力存在缺陷。
